octopamine and urapidil

octopamine has been researched along with urapidil in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adler, G; Alt, A; Ditschuneit, HH; Flechtner-Mors, M; Jenkinson, CP1
Adler, G; Alt, A; Biesalski, HK; Ditschuneit, HH; Flechtner-Mors, M; Jenkinson, CP1

Trials

1 trial(s) available for octopamine and urapidil

ArticleYear
In vivo alpha(1)-adrenergic lipolytic activity in subcutaneous adipose tissue of obese subjects.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 301, Issue:1

    Topics: Adipose Tissue; Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adult; Central Nervous System Depressants; Ethanol; Female; Glycerol; Humans; Lipolysis; Microdialysis; Middle Aged; Norepinephrine; Obesity; Octopamine; Piperazines; Receptors, Adrenergic, alpha-1; Regional Blood Flow; Vasodilator Agents

2002

Other Studies

1 other study(ies) available for octopamine and urapidil

ArticleYear
Sympathetic regulation of glucose uptake by the alpha1-adrenoceptor in human obesity.
    Obesity research, 2004, Volume: 12, Issue:4

    Topics: Adipocytes; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adult; Female; Glucose; Humans; Insulin Resistance; Kinetics; Microdialysis; Middle Aged; Norepinephrine; Octopamine; Piperazines; Receptors, Adrenergic, alpha-1; Sympathetic Nervous System

2004